Prevalence and risk factors of MAFLD and its metabolic comorbidities in community-based adults in China: A cross-sectional study
Authors:
- 7 March 2024
- journal article
- research article
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 18 (3) , 102973
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 37 references indexed in Scilit:
- An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLDClinical Gastroenterology and Hepatology, 2023
- Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort StudyClinical Gastroenterology and Hepatology, 2021
- Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?Hepatology International, 2021
- Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision databaseJournal of Gastroenterology, 2021
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseaseHepatology International, 2020
- Obesity in South Asia: Phenotype, Morbidities, and MitigationCurrent Obesity Reports, 2019
- Global epidemiology of nonalcoholic fatty liver disease: Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2016
- Prevalence and Control of Diabetes in Chinese AdultsJAMA, 2013
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Occupational, commuting, and leisure-time physical activity in relation to risk for Type 2 diabetes in middle-aged Finnish men and womenDiabetologia, 2003